Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Eriksson, E. Sundman, R. Olsson, L. Nilsson, H. Witt, O. Ekberg, R. Kuylenstierna (1997)
Functional Assessment of the Pharynx at Rest and during Swallowing in Partially Paralyzed Humans: Simultaneous Videomanometry and Mechanomyography of Awake Human VolunteersAnesthesiology, 87
H. Berg, J. Viby-Mogensen, J. Roed, C. Mortensen, J. Engbæk, L. Skovgaard, J. Krintel (1997)
Residual neuromuscular block is a risk factor for postoperative pulmonary complications A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuroniumActa Anaesthesiologica Scandinavica, 41
A. Kopman, Lee Zank, Jennifer Ng, G. Neuman (2004)
Antagonism of Cisatracurium and Rocuronium Block at a Tactile Train-of-Four Count of 2: Should Quantitative Assessment of Neuromuscular Function Be Mandatory?Anesthesia & Analgesia, 98
A. Cedborg, E. Sundman, K. Bodén, H. Hedström, R. Kuylenstierna, O. Ekberg, L. Eriksson (2014)
Pharyngeal Function and Breathing Pattern during Partial Neuromuscular Block in the Elderly: Effects on Airway ProtectionAnesthesiology, 120
L. Fortier, D. McKeen, K. Turner, É. Médicis, B. Warriner, P. Jones, A. Chaput, J. Pouliot, A. Galarneau (2015)
The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular BlockadeAnesthesia & Analgesia, 121
K. McCourt, R. Mirakhur, C. Kerr (1999)
Dosage of neostigmine for reversal of rocuronium block from two levels of spontaneous recoveryAnaesthesia, 54
T. Woo, K. Kim, Y. Shim, Mi Kim, S. Yoon, Y. Lim, H. Yang, P. Phiri, J. Chon (2013)
Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patientsKorean Journal of Anesthesiology, 65
S. Schaller, H. Fink, K. Ulm, M. Blobner (2010)
Sugammadex and Neostigmine Dose-finding Study for Reversal of Shallow Residual Neuromuscular BlockAnesthesiology, 113
H. Kirkegaard-Nielsen, H. Helbo-Hansen, Peter Lindholm, I. Severinsen, K. Bülow (1995)
Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.Journal of clinical anesthesia, 7 8
K. Khuenl-Brady, M. Wattwil, B. Vanacker, J. Lora-Tamayo, H. Rietbergen, J. Álvarez-Gómez (2010)
Sugammadex Provides Faster Reversal of Vecuronium-Induced Neuromuscular Blockade Compared with Neostigmine: A Multicenter, Randomized, Controlled TrialAnesthesia & Analgesia, 110
T. Fuchs-Buder, C. Meistelman, F. Alla, Arnaud Grandjean, Yann Wuthrich, F. Donati (2010)
Antagonism of Low Degrees of Atracurium-induced Neuromuscular Blockade: Dose–Effect Relationship for NeostigmineAnesthesiology, 112
H. Ali, R. Wilson, J. Savarese, R. Kitz (1975)
The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans.British journal of anaesthesia, 47 5
H. Illman, P. Laurila, H. Antila, O. Meretoja, S. Alahuhta, K. Olkkola (2011)
The Duration of Residual Neuromuscular Block After Administration of Neostigmine or Sugammadex at Two Visible Twitches During Train-of-Four MonitoringAnesthesia & Analgesia, 112
O. Sacan, P. White, Burcu Tufanogullari, K. Klein (2007)
Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine–Glycopyrrolate and Edrophonium–AtropineAnesthesia & Analgesia, 104
A. Pongrácz, S. Szatmári, R. Nemes, B. Fülesdi, E. Tassonyi (2013)
Reversal of Neuromuscular Blockade with Sugammadex at the Reappearance of Four Twitches to Train-of-four StimulationAnesthesiology, 119
T. Suzuki, H. Mizutani, E. Miyake, N. Fukano, S. Saeki, S. Ogawa (2009)
Infusion requirements and reversibility of rocuronium at the corrugator supercilii and adductor pollicis musclesActa Anaesthesiologica Scandinavica, 53
R Kevin Jones, J. Caldwell, S. Brull, R. Soto (2008)
Reversal of Profound Rocuronium-induced Blockade with Sugammadex: A Randomized Comparison with NeostigmineAnesthesiology, 109
T. Suzuki, G. Masaki, S. Ogawa (2006)
Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.British journal of anaesthesia, 97 2
T. Ledowski, Laura Falke, F. Johnston, E. Gillies, M. Greenaway, Ayala Mel, W. Tiong, M. Phillips (2014)
Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: Sugammadex, neostigmine or no reversalEuropean Journal of Anaesthesiology, 31
F. Herbstreit, J. Peters, M. Eikermann (2009)
Impaired Upper Airway Integrity by Residual Neuromuscular Blockade: Increased Airway Collapsibility and Blunted Genioglossus Muscle Activity in Response to Negative Pharyngeal PressureAnesthesiology, 110
Pim Schol, Ivon Terink, M. Lancé, H. Scheepers (2016)
Liberal or restrictive fluid management during elective surgery: a systematic review and meta-analysis.Journal of clinical anesthesia, 35
Kopman (1997)
765Anesthesiology, 86
M. Naguib, A. Kopman, J. Ensor (2007)
Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis.British journal of anaesthesia, 98 3
G. Murphy, J. Szokol, J. Marymont, S. Greenberg, M. Avram, J. Vender (2008)
Residual Neuromuscular Blockade and Critical Respiratory Events in the Postanesthesia Care UnitAnesthesia & Analgesia, 107
R. Bartkowski (1987)
Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium.Anesthesia and analgesia, 66 7
G. Geldner, M. Niskanen, P. Laurila, V. Mizikov, M. Hübler, G. Beck, H. Rietbergen, E. Nicolayenko (2012)
A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery *Anaesthesia, 67
H. Kirkegaard-Nielsen, J. Caldwell, A. Abengochea, P. Berry, T. Heier (2001)
Does discontinuation of desflurane at the time of neostigmine administration speed recovery from cisatracurium block compared to that with a propofol‐based technique?Acta Anaesthesiologica Scandinavica, 45
M. Blobner, L. Eriksson, J. Scholz, J. Motsch, G. Rocca, M. Prins (2010)
Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trialEuropean Journal of Anaesthesiology, 27
S. Hozo, Benjamin Djulbegovic, I. Hozo (2005)
Estimating the mean and variance from the median, range, and the size of a sampleBMC Medical Research Methodology, 5
B. Plaud, B. Debaene, F. Donati, J. Marty (2010)
Residual Paralysis after Emergence from AnesthesiaAnesthesiology, 112
H. Kirkegaard, T. Heier, J. Caldwell (1998)
Efficacy of Tactile-guided Reversal from Cisatracurium-induced Neuromuscular BlockAnesthesiology, 96
Bevan (1992)
785Anesthesiology, 77
M. Eikermann, Florian Vogt, F. Herbstreit, Mehdi Vahid-Dastgerdi, M. Zenge, Christof Ochterbeck, A. Greiff, J. Peters (2007)
The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade.American journal of respiratory and critical care medicine, 175 1
Xin-min Wu, H. Oerding, Jin Liu, B. Vanacker, S. Yao, V. Dahl, L. Xiong, C. Claudius, Y. Yue, Yuguang Huang, E.A.M. Abels, H. Rietbergen, T. Woo (2014)
Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjectsBMC Anesthesiology, 14
(1991)
Antogonism of atracurium with neostigmine . Effect of dose on speed of recovery
M. Adamus, L. Hrabálek, T. Wanek, T. Gabrhelík, J. Zapletalová (2011)
Intraoperative reversal of neuromuscular block with sugammadex or neostigmine during extreme lateral interbody fusion, a novel technique for spine surgeryJournal of Anesthesia, 25
K. Kim, M. Cheong, H. Lee, J. Lee (2004)
Tactile Assessment for the Reversibility of Rocuronium-Induced Neuromuscular Blockade During Propofol or Sevoflurane AnesthesiaAnesthesia & Analgesia, 99
M. Todd, B. Hindman, B. King (2014)
The Implementation of Quantitative Electromyographic Neuromuscular Monitoring in an Academic Anesthesia DepartmentAnesthesia & Analgesia, 119
Ea Flockton, P. Mastronardi, J. Hunter, C. Gomar, R. Mirakhur, L. Aguilera, Francesco Giunta, C. Meistelman, M. Prins (2008)
Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.British journal of anaesthesia, 100 5
B. Brueckmann, N. Sasaki, P. Grobara, M. Li, T. Woo, J. Bie, M. Maktabi, Jarone Lee, J. Kwo, Richard Pino, A. Sabouri, Francis McGovern, A. Staehr-Rye, A. Staehr-Rye, Matthias Eikermann (2015)
Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.British journal of anaesthesia, 115 5
L. Eriksson, C. Lennmarken, N. Wyon, A. Johnson (1992)
Attenuated ventilatory response to hypoxaemia at vecuronium‐induced partial neuromuscular blockActa Anaesthesiologica Scandinavica, 36
P. White, M. Watcha (1998)
Reversal of neuromuscular blockade.Anesthesia and analgesia, 87 2
S. Beebe (2010)
Upper Airway Impaired by Minimal Neuromuscular Blockade Impaired Upper Airway Integrity by Residual Neuromuscular Blockade : Increased Airway Collapsibility and Blunted Genioglossus Muscle Activity in Response to Negative Pharyngeal Pressure
H. Lemmens, M. El-Orbany, J. Berry, Jovino Morte, G. Martin (2010)
Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine.BMC Anesthesiology, 10
T. Fuchs-Buder, C. Baumann, Julien Guis, P. Guerci, C. Meistelman (2013)
Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trialEuropean Journal of Anaesthesiology, 30
J. Engbaek, D. Ostergaard, J. Viby-Mogensen, L. Skovgaard (1989)
Clinical recovery and train-of-four ratio measured mechanically and electromyographically following atracurium.Anesthesiology, 71 3
M. Eikermann, M. Blobner, H. Groeben, C. Rex, T. Grote, M. Neuhäuser, M. Beiderlinden, J. Peters (2006)
Postoperative Upper Airway Obstruction After Recovery of the Train of Four Ratio of the Adductor Pollicis Muscle from Neuromuscular BlockadeAnesthesia & Analgesia, 102
T. Gaszyński, T. Szewczyk, W. Gaszyński (2012)
Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.British journal of anaesthesia, 108 2
C. Baillard, C. Clec’h, J. Catineau, F. Salhi, G. Gehan, M. Cupa, C. Samama (2005)
Postoperative residual neuromuscular block: a survey of management.British journal of anaesthesia, 95 5
M. Baurain, B. Dernovoi, Alain D'Hollander, D. Hennart, Francis Cantraine (1996)
Conditions to optimise the reversal action of neostigmine upon a vecuronium‐induced neuromuscular blockActa Anaesthesiologica Scandinavica, 40
J. Bevan, L. Collins, Carolyn Fowler, R. Kahwaji, Harold Rosen, Michael Smith, Louis Scheepers, C. Stephenson, D. Bevan (1999)
Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.Anesthesia and analgesia, 89 2
Bevan (1999)
333Anesth Analg, 89
A. Kopman, Pamela Yee, G. Neuman (1997)
Relationship of the Train‐of‐four Fade Ratio to Clinical Signs and Symptoms of Residual Paralysis in Awake VolunteersAnesthesiology, 86
Goldhill (1991)
496Anaesthesia, 46
BACKGROUNDNeostigmine is widely used to antagonise residual paralysis. Over the last decades, the benchmark of acceptable neuromuscular recovery has increased progressively to a train-of-four (TOF) ratio of at least 0.9. Raising this benchmark may impact on the efficacy of neostigmine.OBJECTIVE(S)The systematic review evaluates the efficacy of neostigmine to antagonise neuromuscular block to attain a TOF ratio of at least 0.9.DESIGNWe performed a systematic search of the literature from January 1992 to December 2015.DATA SOURCES OR SETTINGPubMed, EMBASE and the Cochrane Controlled Clinical Trials database were searched for randomised controlled human studies. Search was performed without language restrictions, using the following free text terms: ‘neostigmine’, ‘sugammadex’, ‘edrophonium’ or ‘pyridostigmine’ AND ‘neuromuscular block’, ‘reversal’ or ‘reverse’.ELIGIBILITY CRITERIAStudies were accepted for inclusion if they used quantitative neuromuscular monitoring and neostigmine as the reversal agent. Selected trials were checked by two of the authors for data integrity. Trials relevant for inclusion had to report the number of patients included, the type of anaesthetic maintenance, the type of neuromuscular blocking agent used, the reversal agent and dose used, the depth of neuromuscular block when neostigmine was administered and the reversal time (time from injection of neostigmine until a TOF ratio ≥0.9 was attained).RESULTS19 trials were eligible for quantitative analysis. In patients with deep residual block [T1 (first twitch height) <10%] 70 μg kg−1 neostigmine was used (five trials, 118 patients), and the mean reversal time was 17.1 min (95% confidence interval (CI) [12.4 to 21.8]). In patients with moderate residual block (T1 10% to <25%) the mean neostigmine dose was 56 μg kg−1 (seven trials, 342 patients), and the mean reversal time was 11.3 min (95% CI [9.2 to 13.4]). In patients with a shallow residual block (T1 ≥ 25%) the mean neostigmine dose was 40 μg kg−1 (13 trials, 535 patients), and the mean reversal time was 8.0 min (95% CI [6.8 to 9.2]).CONCLUSIONBased on the findings of this systematic review, we recommend that the administration of neostigmine be delayed until an advanced degree of prereversal recovery has occurred (i.e. a T1 >25% of baseline), or that a recovery time longer than 15 min be accepted.
European Journal of Anaesthesiology – Wolters Kluwer Health
Published: Mar 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.